Jun 16, 2026 08:30AM
Jun 16, 2026 08:30AM
May 6, 2026 04:30PM
Mar 30, 2026 04:45PM
Dec 18, 2025 08:45AM
Dec 18, 2025 08:45AM
Nov 12, 2025 04:30PM DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Aug 12, 2025 04:15PM
Jul 23, 2025 04:30PM
Jul 23, 2025 04:30PM
Jul 21, 2025 08:00AM
Jul 21, 2025 08:00AM
May 29, 2025 06:59AM
May 13, 2025 04:30PM DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights
Mar 17, 2025 04:30PM
Feb 20, 2025 08:15AM
Feb 20, 2025 08:15AM
Dec 3, 2024 08:25AM
Nov 13, 2024 04:20PM
Nov 13, 2024 04:05PM
Oct 9, 2024 08:27AM DiaMedica Therapeutics (DMAC) Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia
Oct 9, 2024 08:27AM
Aug 7, 2024 04:15PM
Jul 11, 2024 08:00AM
Jul 1, 2024 08:04AM
Jul 1, 2024 08:00AM
Jun 26, 2024 08:15AM
Jun 26, 2024 08:15AM DiaMedica Therapeutics Announces $11.8 Million Private Placement
Jun 26, 2024 08:00AM
May 8, 2024 04:30PM
Apr 17, 2024 04:08PM
Mar 19, 2024 04:15PM
Jan 22, 2024 08:23AM
Jan 22, 2024 08:23AM
Nov 13, 2023 04:28PM DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
Sep 12, 2023 08:13AM
Sep 12, 2023 08:13AM
Aug 14, 2023 04:13PM
Jun 26, 2023 08:30AM
Jun 21, 2023 08:39AM
Jun 21, 2023 08:39AM
Jun 21, 2023 08:15AM DiaMedica Therapeutics Inc. (DMAC) Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke
Jun 21, 2023 08:15AM
May 30, 2023 08:29AM
May 30, 2023 08:29AM
May 15, 2023 04:28PM
Apr 11, 2023 08:42AM
Apr 11, 2023 08:41AM
Mar 28, 2023 04:30PM DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results
Nov 9, 2022 04:15PM

323,577 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All